Search

everythinglearnresearchcommunity

for

Search:↓

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

Researchers found potential new targets for treating melanoma and nonmelanoma skin cancers, and identified a possible cause and treatment for male pattern baldness and eczema.

A woman developed thick gums from everolimus treatment after a kidney transplant.

UVB is good for a skin condition in Asian kids, a lotion works for head lice, a drug helps with a skin blistering disorder, a foam reduces itchiness in skin inflammation, birthmarks can be more widespread, and criteria for a neurocutaneous disorder were agreed upon.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Cats with Feline Symmetrical Alopecia can regrow hair with proper treatment based on the specific cause, including diet, medication, or stress management.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

Itch is a common symptom in patients with chronic venous insufficiency, often accompanied by burning and pain.

Diphencyprone treatment protocols could be simplified as no harm occurred despite not fully following them.

Itch is a common symptom in patients with chronic venous insufficiency, often worsening with standing or sitting and occurring mostly in the evening or at night.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Maintaining anticoagulation is crucial for patients with antiphospholipid syndrome.

A woman with lupus had hair loss and skin issues that were successfully treated with medications.

The book is a useful guide for learning about chemical peels, with practical information for all skill levels.

Children's skin diseases need special care and treatment.

Cortisone may help hair regrow by altering the local environment, with regrowth starting 3-4 weeks after treatment, but its use is not widely recommended.

Alopecia areata's causes are unclear, treatments exist but relapses are common.

Low-level laser therapy helps hair growth and reduces hair loss with few side effects.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Alopecia areata progression is linked to stress and hormone changes, suggesting new treatment targets.

A woman had a delayed allergic reaction to the blood thinner enoxaparin, treated with a steroid cream.

A man's red tattoo caused a skin reaction and hair loss in his beard, which improved after treatment.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

A high-fat diet worsens neutrophilic folliculitis by increasing certain chemokines.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.